| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant aromatase inhibitor therapy: Outcomes and safety
|
Janni, Wolfgang
|
|
2010
|
36 |
3 |
p. 249-261
13 p.
|
artikel
|
| 2 |
Bevacizumab as a treatment option in advanced renal cell carcinoma: An analysis and interpretation of clinical trial data
|
McDermott, David F.
|
|
2010
|
36 |
3 |
p. 216-223
8 p.
|
artikel
|
| 3 |
Combined treatment with cytoprotective agents and radiotherapy
|
Winczura, Piotr
|
|
2010
|
36 |
3 |
p. 268-275
8 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2010
|
36 |
3 |
p. IFC-
1 p.
|
artikel
|
| 5 |
Esophagogastric cancer: Targeted agents
|
Ku, Geoffrey Y.
|
|
2010
|
36 |
3 |
p. 235-248
14 p.
|
artikel
|
| 6 |
Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: A good thing?
|
Tabassum, A.
|
|
2010
|
36 |
3 |
p. 230-234
5 p.
|
artikel
|
| 7 |
Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses
|
Shelley, Mike D.
|
|
2010
|
36 |
3 |
p. 195-205
11 p.
|
artikel
|
| 8 |
Late complications of chemotherapy in testicular cancer
|
Pliarchopoulou, Kyriaki
|
|
2010
|
36 |
3 |
p. 262-267
6 p.
|
artikel
|
| 9 |
17q12-21 – The pursuit of targeted therapy in breast cancer
|
Glynn, R.W.
|
|
2010
|
36 |
3 |
p. 224-229
6 p.
|
artikel
|
| 10 |
Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
|
Bosch, Ana
|
|
2010
|
36 |
3 |
p. 206-215
10 p.
|
artikel
|
Tijdschrift beschrijving